Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68d51d9a26579f4bc195771a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ",
"description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ",
"price": 263.0,
"discountamount": 80.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2182,
"imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:46:50.098Z",
"updatedon": "2025-09-25T10:46:50.098Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS MV1 0.2",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68d518ce6b4e65282a1dc798",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg",
"description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)",
"price": 238.0,
"discountamount": 72.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2181,
"imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-25T10:26:22.554Z",
"updatedon": "2025-09-25T10:26:22.554Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDESHINE F 400 CAP",
"category": "ASTHMA RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68bc22e83c3803d861d696a9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CEPHODOXIAA 200",
"description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.",
"price": 185.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2173,
"imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-06T12:02:48.098Z",
"updatedon": "2025-09-08T10:03:20.923Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Cefpodoxime Proxetil Tablets IP 200 mg",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68a40f4d9c559b50b58c317d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "FLUTICATONE PROP NASAL SPRAY",
"description": "Fluticasone Nasal Spray IP is a widely prescribed medication for managing nasal allergies, sneezing, runny nose, and nasal congestion. Marketed under the trusted brand name FLUTICATONE PROP NASAL SPRAY, it provides fast and effective relief from seasonal and perennial allergic rhinitis. Patients suffering from chronic nasal blockage, sinus discomfort, or persistent sneezing often find fluticasone nasal spray as one of the most reliable treatments. With its targeted action, it works directly in the nasal passages to reduce inflammation, making breathing easier and improving overall comfort.\n\nWhat is Fluticasone Nasal Spray IP?\n\nFluticasone belongs to the class of corticosteroids, which are powerful anti-inflammatory agents. When delivered as a nasal spray, it works locally in the nose to reduce swelling, mucus production, and irritation caused by allergens such as dust, pollen, or pet dander.\n\nUnlike oral medications, fluticasone nasal spray acts directly at the site of the problem, providing long-lasting relief with fewer systemic side effects. FLUTICATONE PROP NASAL SPRAY is therefore a safe, convenient, and effective option for patients struggling with allergic symptoms.\n\nUses of Fluticasone Nasal Spray\n\nThe uses of fluticasone nasal spray cover a wide range of allergic and nasal conditions, such as:\n\nRelief from seasonal allergies (hay fever).\n\nControl of perennial allergic rhinitis (year-round symptoms).\n\nReduction of nasal congestion and swelling.\n\nManagement of sneezing, itching, and runny nose.\n\nSupporting patients with sinus discomfort due to allergy-related inflammation.\n\nFor many patients, using FLUTICATONE PROP NASAL SPRAY daily provides consistent relief and helps restore normal breathing.\n\nDosage and How to Use\n\nThe usual recommended dose for adults is one to two sprays in each nostril once daily, or as directed by a doctor.\n\nChildren’s dosage should always be determined by a healthcare provider.\n\nShake the spray bottle gently before each use.\n\nClear nasal passages before spraying for best absorption.\n\nUse consistently for maximum benefit, as the full effect may take a few days.\n\nSide Effects of Fluticasone Nasal Spray\n\nMost patients tolerate fluticasone nasal spray well. However, some may experience mild side effects, including:\n\nDryness or irritation in the nose or throat.\n\nNosebleeds.\n\nMild headache.\n\nSneezing immediately after use.\n\nRarely, changes in sense of taste or smell.\n\nSevere side effects are uncommon, but if patients experience persistent nosebleeds, vision changes, or difficulty breathing, they should consult a doctor immediately.\n\nPrecautions Before Using\n\nBefore starting FLUTICATONE PROP NASAL SPRAY, patients should take the following precautions:\n\nInform the doctor if you have recent nasal surgery or injury.\n\nUse with caution if you have asthma, tuberculosis, or immune system problems.\n\nPregnant and breastfeeding women should use only under medical advice.\n\nAvoid exceeding the recommended dose to prevent unwanted side effects.\n\nRegular monitoring may be advised for patients on long-term use.\n\nDrug Interactions\n\nFluticasone nasal spray may interact with other medicines. Patients should inform their doctor if they are taking:\n\nStrong antifungal medicines (like ketoconazole).\n\nCertain HIV medications (ritonavir, cobicistat).\n\nOther steroid medications.\n\nProper medical guidance ensures safe and effective use without harmful interactions.\n\nWhy Choose Steris Healthcare?\n\nWhen it comes to safe and effective medicines, Steris Healthcare is a name patients and doctors trust. By choosing FLUTICATONE PROP NASAL SPRAY, you get:\n\nA high-quality formulation designed for fast allergy relief.\n\nStrict quality control standards to ensure safety and effectiveness.\n\nA product trusted by healthcare professionals across India.\n\nA patient-centric approach where comfort and results are prioritized.\n\nSteris Healthcare continues to provide advanced solutions in healthcare, making treatments more reliable and accessible for patients.",
"price": 355.0,
"discountamount": 106.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2163,
"imageuri": "https://productimages.withfloats.com/actual/68a4350ea249fc497996ff92.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68a4350ea249fc497996ff92.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-19T05:44:45.438Z",
"updatedon": "2025-08-19T08:25:49.815Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-prop-nasal-spray/2163",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Fluticasone Nasal Spray IP",
"category": "ASTHMA RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68949d4ea0059029dc8c8915",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "BENZTETRA 25",
"description": "BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a specialized medication used primarily to manage involuntary movements associated with neurological disorders. Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor and works by regulating the levels of neurotransmitters such as dopamine, serotonin, norepinephrine, and histamine in the brain. This correction of chemical imbalances helps reduce excessive and uncontrolled muscle movements. BENZTETRA 25 is especially valuable for patients suffering from movement disorders that significantly impact their daily functioning. It helps improve motor control, thereby enhancing quality of life for those affected. This medication is prescribed mainly to treat chorea—a movement disorder characterized by jerky, irregular, and uncontrollable muscle movements—that is caused by Huntington disease.\n\nWhat is BENZTETRA 25?\nBENZTETRA 25 is a therapeutic tablet containing tetrabenazine 25mg, designed to treat involuntary movements (chorea) linked to Huntington disease. It does not cure Huntington disease nor address cognitive or psychiatric symptoms of the disease but effectively reduces the severity of abnormal movements by altering neurotransmitter activity in the brain.\n\nUses of BENZTETRA 25\n\nTo treat chorea (a movement disorder) that is caused by Huntington disease.\n\nTo control involuntary muscle movements in Huntington’s disease patients.\n\nManagement of other hyperkinetic movement disorders as determined by a healthcare provider (such as tardive dyskinesia or Tourette syndrome in some cases).\n\nTo reduce excessive motor activity caused by abnormal nerve signaling in the brain, improving voluntary muscle control.\n\nSide Effects of BENZTETRA 25\n\nDrowsiness and fatigue, which may affect alertness.\n\nInsomnia or difficulty sleeping.\n\nNausea, vomiting, or abdominal discomfort.\n\nParkinsonism symptoms such as tremors, muscle rigidity, and slowed movements (bradykinesia).\n\nMood alterations including depression, anxiety, and in severe cases, suicidal thoughts.\n\nRare serious reactions like allergic responses, heart rhythm irregularities, or neuroleptic malignant syndrome (characterized by high fever, muscle stiffness).\n\nPrecautions Before Using BENZTETRA 25\n\nInform your doctor if you have a history of depression, suicidal thoughts, or any psychiatric illness.\n\nAvoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs).\n\nCaution in patients with cardiac issues due to potential QT interval prolongation.\n\nUse with care when driving or operating machinery as BENZTETRA 25 may cause dizziness or drowsiness.\n\nDo not stop the medication suddenly without consulting your healthcare provider, as symptoms might worsen.\n\nRegular monitoring by a healthcare professional is recommended to assess side effects and efficacy.\n\nDrug Interactions: What Drugs Interact with BENZTETRA 25?\n\nMAO inhibitors such as isocarboxazid, phenelzine, selegiline, and others can cause dangerous interactions and should not be used concurrently.\n\nOther drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of serotonin syndrome.\n\nCaution with other medications known to prolong the QT interval or those affecting dopamine systems.\n\nInteractions with neuroleptics or antipsychotics require close medical supervision due to additive effects on movement and mood.\n\nConclusion\nBENZTETRA 25, containing tetrabenazine 25mg, is a vital medication for managing chorea associated with Huntington disease by modulating neurotransmitter levels in the brain to reduce involuntary movements. While it offers substantial benefits in improving motor control, careful attention to side effects, precautions, and drug interactions is essential for safe and effective use. Always follow the guidance of a healthcare professional when using BENZTETRA 25 to ensure optimal outcomes and safety.",
"price": 425.0,
"discountamount": 128.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2158,
"imageuri": "https://productimages.withfloats.com/actual/68949d54c82f93461bdc841f.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68949d54c82f93461bdc841f.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-07T12:34:22.411Z",
"updatedon": "2025-08-07T12:34:22.411Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/benztetra-25/2158",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "tetrabenazine 25mg",
"category": "NEUROLOGY RANGE",
"tags": [
"tetrabenazine 25mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6891f29bfb7044dfb2d43adf",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "MAGRAL 160",
"description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.",
"price": 810.0,
"discountamount": 243.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2156,
"imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-05T12:01:31.195Z",
"updatedon": "2025-08-05T12:01:31.195Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "megestrol acetate 160 mg",
"category": "Gynaecology",
"tags": [
"megestrol acetate 160 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6864fe81c4418d1ebb0d08eb",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "STERIS DPI DEVICE",
"description": "The STERIS DPI DEVICE is a modern, user-friendly Dry Powder Inhaler (DPI) designed to deliver respiratory medication directly to the lungs in a highly efficient and portable form. Inhalation therapy plays a critical role in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The DPI device simplifies this process by delivering the drug in the form of a dry powder without the need for coordination between actuation and inhalation, making it ideal for patients of all ages.\n\nWhat is a DPI Device?\nA Dry Powder Inhaler (DPI) is a medical device used to deliver therapeutic medication directly into the lungs. Unlike traditional inhalers that use propellants to push the drug into the lungs, DPI devices rely on the patient’s own inhalation power to disperse and inhale the powdered drug effectively. Essentially, a DPI device is a tool that administers medication in dry powder form to the lungs, providing quick and targeted respiratory relief.\n\nDPI Full Form: Dry Powder Inhaler\n\nUses of STERIS DPI DEVICE\nThe STERIS DPI DEVICE is commonly used in the treatment and management of respiratory diseases such as:\n\nAsthma\n\nChronic Obstructive Pulmonary Disease (COPD)\n\nBronchitis\n\nAllergic airway conditions\n\nIt helps deliver medication directly to the airways, ensuring faster action and reduced systemic side effects compared to oral treatments.\n\nHow It Works\nWhen the patient inhales through the mouthpiece, the device uses the airflow to disperse the dry powder into fine particles, allowing it to reach deep into the lungs. The inhaled medication begins working quickly to open airways, reduce inflammation, or treat infection, depending on the formulation used with the DPI.\n\nSide Effects of Dry Powder Inhaler Use\nWhile the STERIS DPI DEVICE itself is safe and user-friendly, some medications delivered via DPI may cause minor side effects such as:\n\nDry throat or mouth\n\nHoarseness\n\nCough\n\nIrritation in the throat\n\nFungal infections in the mouth (if corticosteroids are used and mouth is not rinsed after use)\n\nThese side effects can often be minimized with proper usage and hygiene.\n\nPrecautions Before Using STERIS DPI DEVICE\nAlways read the instructions carefully before first-time use.\n\nMake sure the device is clean and free from moisture.\n\nInhale deeply and forcefully to ensure proper medication delivery.\n\nDo not exhale into the device, as moisture can affect the powder's consistency.\n\nStore in a dry, cool place away from direct sunlight.\n\nAlways rinse your mouth after using corticosteroid-based powders.\n\nAdvantages of STERIS DPI DEVICE\nPropellant-free and eco-friendly\n\nPortable and compact design for daily use\n\nNo coordination required between inhalation and actuation\n\nDelivers medication effectively with minimal effort\n\nEasy-to-use, even for elderly or pediatric patients\n\nConclusion\nThe STERIS DPI DEVICE is a highly effective solution for individuals suffering from chronic or acute respiratory disorders. By delivering medication directly to the lungs in a dry powder form, it ensures fast relief, greater bioavailability, and improved patient compliance. Whether you’re managing asthma or COPD, this DPI device offers a dependable and convenient way to breathe easier every day.",
"price": 255.0,
"discountamount": 77.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"coordination required",
"inhalation power",
"inhalation making",
"breathe easier",
"individuals suffering",
"compact design",
"ecofriendly portable",
"direct sunlight",
"instructions carefully",
"hygiene precautions",
"proper usage",
"medications delivered",
"reach deep",
"oral treatments",
"critical role",
"medical device",
"patient inhales",
"administers medication",
"highly efficient",
"respiratory diseases",
"dpi device",
"dry throat",
"dry powder",
"side effects",
"moisture inhale deeply",
"delivering medication directly",
"lungs providing quick",
"dry powder form",
"chronic respiratory conditions",
"pediatric patients conclusion",
"dpi device offers",
"dpi device simplifies",
"steris dpi device",
"dpi side effects",
"youre managing asthma",
"dry powder inhaler",
"minor side effects",
"improved patient compliance",
"highly effective solution",
"throat fungal infections",
"dry cool place",
"acute respiratory disorders",
"minimal effort easytouse",
"corticosteroidbased powders advantages",
"powders consistency store",
"treat infection depending",
"fine particles allowing"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2142,
"imageuri": "https://productimages.withfloats.com/actual/6864feb4c75fa610aeaeaeda.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6864feb4c75fa610aeaeaeda.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-02T09:40:17.078Z",
"updatedon": "2025-07-02T13:03:34.654Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/steris-dpi-device/2142",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Dry powder inhaler",
"category": "RESPIRTORYRANGE",
"tags": [
"Dry powder inhaler"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863dbebfa62312b851d2551",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "OSELTATERIS ORAL SUSPENSION",
"description": "OSELTATERIS Oral Suspension is a powerful antiviral medication formulated with Oseltamivir Phosphate at a strength of 12 mg/ml, designed for pediatric and adult use. Manufactured under strict quality standards, this oral suspension is used to prevent and treat infections caused by the flu virus, specifically influenza A and B. It works by stopping the spread of the flu virus in the body, reducing the severity and duration of symptoms. OSELTATERIS is especially effective when administered within the first 48 hours of symptom onset.\n\nWhat is Oseltamivir Phosphate Oral Suspension IP 12 mg?\nOseltamivir Phosphate Oral Suspension IP 12 mg is an antiviral medication belonging to the class of neuraminidase inhibitors. This oral formulation is primarily used to prevent and treat flu infections, including seasonal outbreaks and pandemics. The suspension is easy to administer and is typically prescribed for infants, children, or adults who are unable to swallow capsules.\n\nUses of Oseltamivir Phosphate Oral Suspension IP 12 mg/ml\nOSELTATERIS is recommended for the following uses:\n\nTreatment of influenza A and B infections in individuals aged 2 weeks and older\n\nPrevention of influenza in individuals exposed to flu-infected patients or during community outbreaks\n\nReduces flu-related complications such as bronchitis, pneumonia, and ear infections\n\nShortens the duration of symptoms like fever, cough, sore throat, fatigue, and body aches\n\nPrevents and treats infections caused by the flu virus\n\nPossible Side Effects\nLike any medication, oseltamivir phosphate oral suspension IP 12 mg may cause side effects, ranging from mild to serious. Most side effects are temporary and manageable:\n\nCommon side effects include:\n\nNausea\n\nVomiting\n\nAbdominal pain\n\nHeadache\n\nDizziness\n\nLess common or serious side effects include:\n\nSkin rashes or allergic reactions\n\nHallucinations, confusion, or abnormal behavior (especially in children)\n\nSeizures (rare)\n\nSevere vomiting or dehydration\n\nSwelling of the face, lips, or throat\n\nSeek immediate medical attention if any severe allergic reactions or behavioral changes occur.\n\nPrecautions Before Using\nBefore taking OSELTATERIS, consider the following precautions:\n\nInform your doctor if you are allergic to Oseltamivir or any other antiviral drugs\n\nDisclose any history of kidney disease, heart conditions, or chronic respiratory illness\n\nIf pregnant or breastfeeding, consult your healthcare provider before use\n\nDo not use this medication for viral infections other than influenza\n\nComplete the full course even if symptoms improve early to prevent resistance\n\nUse the exact dose prescribed; do not double up on missed doses\n\nDrug Interactions\nOseltamivir may interact with other medications, which can affect its efficacy or increase the risk of side effects.\n\nWhat drugs interact with Oseltamivir Phosphate Oral Suspension IP 12 mg?\n\nLive attenuated influenza vaccine (nasal flu vaccine): Avoid taking oseltamivir 2 weeks before or 48 hours after receiving the nasal flu vaccine, as it may interfere with the vaccine's effectiveness\n\nProbenecid: May increase oseltamivir levels in the body, leading to enhanced effects or toxicity\n\nMethotrexate or Cyclophosphamide: Increased risk of side effects when used concurrently\n\nAnticoagulants (e.g., warfarin): Monitor closely due to possible changes in clotting times\n\nAlways inform your doctor about any vitamins, herbal supplements, or over-the-counter medicines you are using\n\nConclusion\nOSELTATERIS Oral Suspension is a trusted antiviral solution for both prevention and treatment of influenza infections. With the active ingredient oseltamivir phosphate oral suspension IP 12 mg/ml, it effectively reduces the flu’s severity and duration while minimizing the risk of complications. Its child-friendly liquid formulation makes it a reliable choice for families during flu season. Always use under medical supervision for best results and safety.",
"price": 841.0,
"discountamount": 253.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"48 hours",
"prevent resistance",
"flus severity",
"influenza complete",
"precautions inform",
"older prevention",
"oral suspension",
"influenza infections",
"medical supervision",
"reliable choice",
"effectively reduces",
"overthecounter medicines",
"clotting times",
"concurrently anticoagulants",
"toxicity methotrexate",
"drugs interact",
"healthcare provider",
"breastfeeding consult",
"taking oseltateris",
"occur precautions",
"medical attention",
"throat seek",
"face lips",
"dehydration swelling",
"abnormal behavior",
"skin rashes",
"bronchitis pneumonia",
"fluinfected patients",
"individuals exposed",
"swallow capsules",
"infants children",
"seasonal outbreaks",
"oral formulation",
"neuraminidase inhibitors",
"symptom onset",
"symptoms oseltateris",
"12 mgml designed",
"oseltamivir phosphate",
"enhanced effects",
"side effects",
"body leading",
"body reducing",
"flu season",
"flu virus",
"viral infections",
"typically prescribed",
"increase oseltamivir levels",
"side effects ranging",
"cyclophosphamide increased risk",
"treat flu infections",
"symptoms improve early",
"severe allergic reactions",
"antiviral medication belonging",
"body aches prevents",
"nasal flu vaccine",
"treats infections caused",
"ear infections shortens",
"treat infections caused",
"exact dose prescribed",
"antiviral drugs disclose",
"trusted antiviral solution",
"vitamins herbal supplements",
"vaccines effectiveness probenecid",
"chronic respiratory illness",
"strict quality standards"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2141,
"imageuri": "https://productimages.withfloats.com/actual/6863dbeea63c56c75af5face.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6863dbeea63c56c75af5face.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T13:00:27.331Z",
"updatedon": "2025-07-01T13:00:27.331Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/oseltateris-oral-suspension/2141",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "oseltamivir phosphate oral suspension",
"category": "PEDIATRICS",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863d70eaf0c9d1aa0c2d3e5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "FLUTICATONE VILO 200",
"description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 years",
"24 hours",
"increased risk",
"drugs interact",
"antiviral medications",
"recommended dose",
"airways open",
"reduce inflammation",
"acute asthma",
"asthma attacks",
"severe asthma",
"copd attacks",
"inhaler consistently",
"optimal results",
"breathing comfort",
"longacting bronchodilation",
"antiinflammatory power",
"inhaled corticosteroids",
"vilanterol antifungal",
"tricyclic antidepressants",
"taking betablockers",
"prescribed inform",
"tuberculosis rinse",
"headache hoarseness",
"initial phase",
"generally welltolerated",
"fluticatone vilo 200",
"exercise capacity",
"emphysema reduces",
"chronic bronchitis",
"relaxing muscles",
"rescue medicine",
"vilanterol relaxes",
"prevent symptoms",
"specially formulated",
"vilanterol 25 mcg",
"vilanterol powder",
"rare effects",
"ketoconazole ritonavir",
"healthcare provider",
"therapy common",
"potent corticosteroid",
"fluticasone furoate",
"side effects",
"lung function",
"vilanterol fluticasone furoate",
"copd exacerbations improves",
"inhalation fluticasone furoate",
"lung function quality",
"fixeddose inhalation powder",
"increase corticosteroid levels",
"fastacting inhaler inform",
"combination inhalation therapy",
"side effects consult",
"frequent side effects",
"inhalation longterm treatment",
"healthcare providers guidance",
"ritonavir itraconazole leading",
"highly effective corticosteroid",
"effective oncedaily treatment",
"heart rhythm disturbances",
"strong cyp3a4 inhibitors",
"hypokalemia mao inhibitors",
"atenolol propranolol diuretics",
"breastfeeding drug interactions",
"pregnant planning pregnancy",
"avoid oral thrush",
"sore throat cough",
"adolescents maintenance treatment",
"longterm maintenance treatment",
"prescription combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2140,
"imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:39:42.59Z",
"updatedon": "2025-07-04T07:41:47.804Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "fluticasone furoate and vilanterol powder for inhalation",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}